Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brunner

Showing results (771-780 of 906) with videos related to

Pageof 91
Sort By:
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824AJ Nussberger, M de Gasparo, L Juillerat, et al.
British Journal of Clinical Pharmacology|December 1, 1981
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteersM Burnier, G A Turini, H R Brunner, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 31, 1999
Coronary and peripheral artery remodeling in patients undergoing PTCA: An intracoronary and transcutaneous ultrasound studyE Delacrétaz, M Fleisch, U P Kaufmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2000
Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptorsC Pellieux, T Sauthier, A Domenighetti, et al.
Anticancer Research|April 13, 2001
P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patientsS Zöchbauer-Müller, M Filipits, M Rudas, et al.
Lancet (London, England)|February 4, 1995
Candida albicans endophthalmitis after anabolic steroid abuseR A Widder, K U Bartz-Schmidt, H Geyer, et al.
Journal of Hypertension|January 1, 1990
Prevention of renal hypertension in the rat by neuropeptide YB Waeber, D Evéquoz, J F Aubert, et al.
Perspectives on Medical Education|April 5, 2020
The organic formation of a wellness committee: A unique, student-led approach to implementing a wellness program in medical schoolMichael R Brunner, Daniel Peters, Mary Virginia Portera, et al.
Clinical Pharmacology and Therapeutics|May 1, 1986
Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjectsJ P Bussien, T F d'Amore, L Perret, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 9, 1999
Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthaseJ A Haefliger, P Meda, A Formenton, et al.
Pageof 91

Showing results (771-780 of 906) with videos related to

Sort By:
Pageof 91
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824AJ Nussberger, M de Gasparo, L Juillerat, et al.
British Journal of Clinical Pharmacology|December 1, 1981
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteersM Burnier, G A Turini, H R Brunner, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 31, 1999
Coronary and peripheral artery remodeling in patients undergoing PTCA: An intracoronary and transcutaneous ultrasound studyE Delacrétaz, M Fleisch, U P Kaufmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2000
Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptorsC Pellieux, T Sauthier, A Domenighetti, et al.
Anticancer Research|April 13, 2001
P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patientsS Zöchbauer-Müller, M Filipits, M Rudas, et al.
Lancet (London, England)|February 4, 1995
Candida albicans endophthalmitis after anabolic steroid abuseR A Widder, K U Bartz-Schmidt, H Geyer, et al.
Journal of Hypertension|January 1, 1990
Prevention of renal hypertension in the rat by neuropeptide YB Waeber, D Evéquoz, J F Aubert, et al.
Perspectives on Medical Education|April 5, 2020
The organic formation of a wellness committee: A unique, student-led approach to implementing a wellness program in medical schoolMichael R Brunner, Daniel Peters, Mary Virginia Portera, et al.
Clinical Pharmacology and Therapeutics|May 1, 1986
Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjectsJ P Bussien, T F d'Amore, L Perret, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 9, 1999
Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthaseJ A Haefliger, P Meda, A Formenton, et al.
Pageof 91